CYP2A6-IN-2
CYP2A6-IN-2 (compound 5) is a CYP2A6 inhibitor. CYP2A6-IN-2 can be used in the study of nicotine dependence[1].
Product Specifications
CAS Number
[912291-11-3]
UNSPSC
12352005
Hazard Statement
H314
Target
Cytochrome P450
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/cyp2a6-in-2.html
Purity
97.61
Smiles
FC(C1=CC(CNCC(C)C)=CC=C1)(F)F
Molecular Formula
C12H16F3N
Molecular Weight
231.26
Precautions
H314
References & Citations
[1]Omar Ghosheh, et al. Substituted benzylamines as cyp2a inhibitors and uses thereof to treat nicotine dependence. WO, WO2006108149. 2006-10-12.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
126524-ML550 100 µL
EXTL2 (Exostosin-like 2, Alpha-1,4-N-acetylhexosaminyltransferase EXTL2, Alpha-GalNAcT EXTL2, EXT-related Protein 2, Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase, EXTR2) (MaxLight 550)
Ask
View Details